Announcements Trials
Browse Landscape

Phase

Phase 1 26Phase 2 23Phase 3 20Phase 4 18Phase 1/2 8Phase EARLY_PHASE1 6Phase NA 5Phase 2/3 4

Status

Unknown 2Completed 2

Sponsor Class

OTHER 2FED 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Dermatologic 1

Conditions

Uterine Cervical Dysplasia 2Melanoma 1Hutchinson's Melanotic Freckle 1Bowen's Disease 1

Interventions

Cisplatin 98Gemcitabine 66Paclitaxel 62Carboplatin 60Fluorouracil 59Docetaxel 59Capecitabine 59Oxaliplatin 56Cyclophosphamide 54Radiotherapy 50Drug Therapy 46Bevacizumab 38pembrolizumab 35Dexamethasone 33Magnetic Resonance Spectroscopy 32Leucovorin 32Doxorubicin 31Cytarabine 27Etoposide 26Pemetrexed 25Nivolumab 24Methotrexate 24Radiation 20Vincristine 18venetoclax 17apatinib 17Rituximab 17Prednisone 17Letrozole 17Irinotecan 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Imiquimod × Clear all
NCT01088737 2019-08-13

Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna

Medical University of Graz

Phase 2/3 Unknown
60 enrolled
Dermatologic

Melanoma, Hutchinson's Melanotic Freckle

NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed
22 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00941252 2011-01-24

ITIC

Medical University of Vienna

Phase 2/3 Completed
60 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT00384124 2008-03-26

Topical Imiquimod for Bowen's Disease of the Head and Neck

Brooke Army Medical Center

Phase 2/3 Unknown
50 enrolled

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡